Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
7073518
Reference Type
Journal Article
Title
A Simple Platform for the Rapid Development of Antimicrobials
Author(s)
Partearroyo, T; Varela-Moreiras, LG; de Lourdes Samaniego-Vaesken, M; Ruiz, E; Olza, J; Aranceta-Bartrina, J; Gil, A; Gonzalez-Gross, M; Cheung, T; Serra-Majem, L; ,
Year
2017
Is Peer Reviewed?
1
Journal
Scientific Reports
EISSN:
2045-2322
Publisher
NATURE PUBLISHING GROUP
Location
LONDON
Volume
7
PMID
29242618
DOI
10.1038/s41598-017-17941-7
Web of Science Id
WOS:000417902200025
Abstract
Recent infectious outbreaks highlight the need for platform technologies that can be quickly deployed to develop therapeutics needed to contain the outbreak. We present a simple concept for rapid development of new antimicrobials. The goal was to produce in as little as one week thousands of doses of an intervention for a new pathogen. We tested the feasibility of a system based on antimicrobial synbodies. The system involves creating an array of 100 peptides that have been selected for broad capability to bind and/or kill viruses and bacteria. The peptides are pre-screened for low cell toxicity prior to large scale synthesis. Any pathogen is then assayed on the chip to find peptides that bind or kill it. Peptides are combined in pairs as synbodies and further screened for activity and toxicity. The lead synbody can be quickly produced in large scale, with completion of the entire process in one week.
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity